EXHIBIT 32.2

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

         I, Fanjun Wu, certify, pursuant to 18 U.S.C. Section 1350, as adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly
Report of Sunwin International Neutraceuticals, Inc. on Form 10-Q for the period
ended July 31, 2008 fully complies with the requirements of Section 13(a) or
15(d) of the Securities Exchange Act of 1934 and that information contained in
such Quarterly Report on Form 10-QSB fairly presents in all material respects
the financial condition and results of operations of Sunwin International
Neutraceuticals, Inc.

Dated: September 15, 2008              By: /s/ Fanjun Wu
                                           -------------
                                           Fanjun Wu, Chief Financial Officer

[A signed original of this written statement required by Section 906 has been
provided to Sunwin International Neutraceuticals, Inc. and will be retained by
Sunwin International Neutraceuticals, Inc. and furnished to the United States
Securities and Exchange Commission or its staff upon request.]